The Indus Hospital Blood Center Now Complies With Federal Drug Association (FDA, USA) Requirement For Donor Screening

Since April 2018, Nucleic Acid Testing (NAT) using Polymerase Chain Reaction (PCR) technology is being used for identifying Hepatitis B and Hepatitis C viruses on every single donor in addition to CLIA which was already being performed. Thus fulfilling FDA (USA) requirement for donor screening.

No comments yet.

Leave a comment

Your email address will not be published.

Mode of Payment

Accordion Sample DescriptiIndus Health Australia limited (IHA) Account details BSB. 062 000 Acc No: 17215717 Bank: Common Wealth Bankon
Please issue your cheques payable to “Indus Health Australia limited (IHA)” and mail to following address 76 St. George Crescent Sandy Point NSW, 2172
Mode of Payment